1.Minimally Invasive Single-Site Cholecystectomy in Obese Patients: Laparoscopic vs. Robotic
Kyu Min LEE ; Dae Hun HAN ; Seoung Yoon ROH ; Ho Kyoung HWANG ; Woo Jung LEE ; Chang Moo KANG
Journal of Minimally Invasive Surgery 2019;22(3):101-105
		                        		
		                        			
		                        			PURPOSE: Laparoscopic cholecystectomy is treatment method for management of benign gallbladder diseases. Further attempts are made to operate single-port laparoscopic cholecystectomy. However, single-port laparoscopic cholecystectomy, the procedure remains technically difficult, especially in obese patient. Recently, a robotic surgical system for minimal invasive surgery was introduced to overcome the limitations of conventional laparoscopic surgery. METHODS: From April 2009 to August 2017, we retrospectively reviewed the medical records of patients with single-site, minimally invasive (laparoscopic and robotic) cholecystectomy with high BMI (>25 kg/m2). We analyzed general characteristics and perioperative outcomes between the single-fulcrum laparoscopic cholecystectomy group and the robotic single-site cholecystectomy (RSSC) group. RESULTS: Operation time (57.56±11.10 vs 98.5±12.28 p<0.001) was significantly longer and postoperative pain score (3.61 vs 5.15 p=0.000) was significantly higher in the robotic single-site cholecystectomy (RSSC) group, but the actual dissection time (25.85±11.09 vs 25.79±13.35 p=0.978) was not significantly different between the two approaches. Iatrogenic gallbladder perforation, (13 vs 6 p=0.005), patients undergoing RSSC showed a significantly smaller amount than did those undergoing single-fulcrum laparoscopic cholecystectomy (SFLC). CONCLUSION: It is difficult to say for certain that RSSC is clearly better than SFLC in obese patients. However, because of the technical convenience and efficiency of surgery with RSSC, RSSC can be practically worthwhile. Further study is mandatory.
		                        		
		                        		
		                        		
		                        			Cholecystectomy
		                        			;
		                        		
		                        			Cholecystectomy, Laparoscopic
		                        			;
		                        		
		                        			Gallbladder
		                        			;
		                        		
		                        			Gallbladder Diseases
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Laparoscopy
		                        			;
		                        		
		                        			Medical Records
		                        			;
		                        		
		                        			Methods
		                        			;
		                        		
		                        			Obesity
		                        			;
		                        		
		                        			Pain, Postoperative
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Robotic Surgical Procedures
		                        			
		                        		
		                        	
2.Risk of cancer in pre-dialysis chronic kidney disease: A nationwide population-based study with a matched control group
Sehoon PARK ; Soojin LEE ; Yaerim KIM ; Yeonhee LEE ; Min Woo KANG ; Kyungdo HAN ; Seoung Seok HAN ; Hajeong LEE ; Jung Pyo LEE ; Kwon Wook JOO ; Chun Soo LIM ; Yon Su KIM ; Dong Ki KIM
Kidney Research and Clinical Practice 2019;38(1):60-70
		                        		
		                        			
		                        			BACKGROUND: Cancer risk and epidemiology in pre-dialysis chronic kidney disease (CKD) warrant further investigation in a large-scale cohort. METHODS: We performed a nationwide population-based study using the national health insurance database of Korea. We screened records from 18,936,885 individuals who received a national health examination ≥ 2 times from 2009 to 2016. Pre-dialysis CKD was identified based on serum creatinine and dipstick albuminuria results. Individuals with preexisting cancer history, renal replacement therapy, or transient CKD were excluded. A control group without evidence of kidney function impairment and matched for age, sex, low-income status, and smoking history was included. Risk of cancers, as identified in the claims database, was investigated using a multivariable Cox regression model including matched variables and other unmatched clinical characteristics as covariates. RESULTS: A total of 471,758 people with pre-dialysis CKD and the same number of matched controls were included. Urinary (adjusted hazard ratio [HR], 1.97; 95% confidence interval [95% CI], 1.82–2.13) and hematopoietic (adjusted HR, 1.53; 95% CI, 1.38–1.68) malignancy risk was increased in pre-dialysis CKD and all CKD stages. However, the risk of digestive cancer was lower in the pre-dialysis CKD group (adjusted HR, 0.89; 95% CI, 0.87–0.92). The risk of digestive, respiratory, thyroid, and prostate malignancy demonstrated a non-linear association with CKD stage, with stage 1 or stage 4/5 CKD without dialysis demonstrating relatively lower risk. CONCLUSION: Cancer risk varied in pre-dialysis CKD compared to controls, and the association between cancer risk and CKD stage varied depending on the cancer type.
		                        		
		                        		
		                        		
		                        			Albuminuria
		                        			;
		                        		
		                        			Cohort Studies
		                        			;
		                        		
		                        			Comorbidity
		                        			;
		                        		
		                        			Creatinine
		                        			;
		                        		
		                        			Dialysis
		                        			;
		                        		
		                        			Epidemiology
		                        			;
		                        		
		                        			Kidney
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			National Health Programs
		                        			;
		                        		
		                        			Prostate
		                        			;
		                        		
		                        			Renal Insufficiency, Chronic
		                        			;
		                        		
		                        			Renal Replacement Therapy
		                        			;
		                        		
		                        			Smoke
		                        			;
		                        		
		                        			Smoking
		                        			;
		                        		
		                        			Thyroid Gland
		                        			
		                        		
		                        	
3.Current characteristics of dialysis therapy in Korea: 2016 registry data focusing on diabetic patients.
Dong Chan JIN ; Sung Ro YUN ; Seoung Woo LEE ; Sang Woong HAN ; Won KIM ; Jongha PARK ; Yong Kyun KIM
Kidney Research and Clinical Practice 2018;37(1):20-29
		                        		
		                        			
		                        			Diabetic nephropathy is the most frequent cause of end-stage renal disease worldwide. Dialysis patients with diabetes mellitus (DM) have more complications and shorter survival duration than non-DM dialysis patients, requiring more clinical attention and difficult management. The registry committee of the Korean Society of Nephrology has collected data about dialysis therapy in Korea through an on-line registry program and analyzed the characteristics of patients. A survey of dialysis patients in 2016 showed that 50.2% of new dialysis patients had DM nephropathy as the cause of end-stage renal disease. The proportion of patients receiving hemodialysis (HD) for more than 5 years was 38% in DM patients and 51% in non-DM patients. The mean pulse pressure in DM HD patients was 71.5 mmHg, compared with 62.6 mmHg in non-DM patients. The proportion of DM patients with native vessel arteriovenous fistula as vascular access for HD was lower than that of non-DM patients (73% vs. 78%). Mean serum creatinine of DM and non-DM dialysis patients was 8.4 mg/dL and 9.5 mg/dL respectively. As vascular access of the DM HD patients was poor, the dialysis adequacy of DM patients was slightly lower than that of non-DM patients. The 5-year survival rate for DM HD patients was 53.9%, which was much lower than that of chronic glomerulonephritis patients (78.2%). The proportion of patients with a full-time job was 17% for DM patients and 28% for non-DM patients.
		                        		
		                        		
		                        		
		                        			Arteriovenous Fistula
		                        			;
		                        		
		                        			Blood Pressure
		                        			;
		                        		
		                        			Creatinine
		                        			;
		                        		
		                        			Diabetes Mellitus
		                        			;
		                        		
		                        			Diabetic Nephropathies
		                        			;
		                        		
		                        			Dialysis*
		                        			;
		                        		
		                        			Glomerulonephritis
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Kidney Failure, Chronic
		                        			;
		                        		
		                        			Korea*
		                        			;
		                        		
		                        			Nephrology
		                        			;
		                        		
		                        			Renal Dialysis
		                        			;
		                        		
		                        			Renal Replacement Therapy
		                        			;
		                        		
		                        			Survival Rate
		                        			
		                        		
		                        	
4.Changes in Hyolaryngeal Movement During Swallowing in the Lateral Decubitus Posture.
Byung Mo OH ; Jae Hyun LEE ; Han Gil SEO ; Woo Hyung LEE ; Tai Ryoon HAN ; Seoung Uk JEONG ; Ho Joong JEONG ; Young Joo SIM
Annals of Rehabilitation Medicine 2018;42(3):416-424
		                        		
		                        			
		                        			OBJECTIVE: To investigate the differences in hyolaryngeal kinematics at rest and during swallowing in the upright sitting (UP) and the lateral decubitus (LD) postures in healthy adults, and delineating any potential advantages of swallowing while in the LD posture. METHODS: Swallowing was videofluoroscopically evaluated in 20 healthy volunteers in UP and LD postures, based on the movements of hyoid bone, vocal folds, and the bolus head. Parameters included the Penetration-Aspiration Scale (PAS), horizontal and vertical displacement, horizontal and vertical initial position, horizontal and vertical peak position, time to peak position of the hyoid bone and vocal folds, and pharyngeal transit time (PTT). RESULTS: Nine participants were rated PAS 2 in the UP and 1 was rated PAS 2 in the LD (p=0.003) at least 1 out of 3 swallows each posture. The hyoid and vocal folds showed more anterior and superior peak and initial positions in the LD. In addition, swallowing resulted in greater vertical and smaller horizontal displacement of the hyoid in LD posture compared with UP. Time to peak position of the hyoid was shorter in LD. The maximal vertical and horizontal displacement of the vocal folds, and PTT were comparable between postures. CONCLUSION: The results showed that the peak and initial positions of the hyoid and larynx and the pattern of hyoid movement varied significantly depending on the body postures. This study suggests that the LD posture was one of the safe feeding postures without any increased risk compared with UP posture.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Biomechanical Phenomena
		                        			;
		                        		
		                        			Deglutition Disorders
		                        			;
		                        		
		                        			Deglutition*
		                        			;
		                        		
		                        			Head
		                        			;
		                        		
		                        			Healthy Volunteers
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hyoid Bone
		                        			;
		                        		
		                        			Larynx
		                        			;
		                        		
		                        			Posture*
		                        			;
		                        		
		                        			Swallows
		                        			;
		                        		
		                        			Vocal Cords
		                        			
		                        		
		                        	
5.Healthcare Costs for Acute Hospitalized and Chronic Heart Failure in South Korea: A Multi-Center Retrospective Cohort Study.
Hyemin KU ; Wook Jin CHUNG ; Hae Young LEE ; Byung Soo YOO ; Jin Oh CHOI ; Seoung Woo HAN ; Jieun JANG ; Eui Kyung LEE ; Seok Min KANG
Yonsei Medical Journal 2017;58(5):944-953
		                        		
		                        			
		                        			PURPOSE: Although heart failure (HF) is recognized as a leading contributor to healthcare costs and a significant economic burden worldwide, studies of HF-related costs in South Korea are limited. This study aimed to estimate HF-related costs per Korean patient per year and per visit. MATERIALS AND METHODS: This retrospective cohort study analyzed data obtained from six hospitals in South Korea. Patients with HF who experienced ≥one hospitalization or ≥two outpatient visits between January 1, 2013 and December 31, 2013 were included. Patients were followed up for 1 year [in Korean won (KRW)]. RESULTS: Among a total of 500 patients (mean age, 66.1 years; male sex, 54.4%), the mean 1-year HF-related cost per patient was KRW 2,607,173, which included both, outpatient care (KRW 952,863) and inpatient care (KRW 1,654,309). During the post-index period, 22.2% of patients had at least one hospitalization, and their 1-year costs per patient (KRW 8,530,290) were higher than those of patients who had only visited a hospital over a 12-month period (77.8%; KRW 917,029). Among 111 hospitalized patients, the 1-year costs were 1.7-fold greater in patients (n=52) who were admitted to the hospital via the emergency department (ED) than in those (n=59) who were not (KRW 11,040,453 vs. KRW 6,317,942; p<0.001). CONCLUSION: The majority of healthcare costs for HF patients in South Korea was related to hospitalization, especially admissions via the ED. Appropriate treatment strategies including modification of risk factors to prevent or decrease hospitalization are needed to reduce the economic burden on HF patients.
		                        		
		                        		
		                        		
		                        			Ambulatory Care
		                        			;
		                        		
		                        			Cohort Studies*
		                        			;
		                        		
		                        			Delivery of Health Care*
		                        			;
		                        		
		                        			Emergency Service, Hospital
		                        			;
		                        		
		                        			Health Care Costs*
		                        			;
		                        		
		                        			Heart Failure*
		                        			;
		                        		
		                        			Heart*
		                        			;
		                        		
		                        			Hospitalization
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Inpatients
		                        			;
		                        		
		                        			Korea*
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Outpatients
		                        			;
		                        		
		                        			Retrospective Studies*
		                        			;
		                        		
		                        			Risk Factors
		                        			
		                        		
		                        	
6.Artificial Pancreas: A Concise Review.
Sang Youl RHEE ; Seoung Woo HAN ; Jeong Taek WOO
Journal of Korean Diabetes 2017;18(3):141-149
		                        		
		                        			
		                        			Artificial pancreas is a technique developed to automatically control blood glucose in people with diabetes by providing an endocrine function instead of a healthy pancreas. The technique was developed for the replacement of insulin secretion deficiencies among various exocrine and endocrine functions of the pancreas and is mainly used for people with type 1 diabetes or those who need intensive insulin treatment. This review briefly summarizes the working principles, components, recent clinical research, and future perspectives of artificial pancreas.
		                        		
		                        		
		                        		
		                        			Blood Glucose
		                        			;
		                        		
		                        			Diabetes Mellitus
		                        			;
		                        		
		                        			Extracellular Fluid
		                        			;
		                        		
		                        			Glucose
		                        			;
		                        		
		                        			Insulin
		                        			;
		                        		
		                        			Pancreas
		                        			;
		                        		
		                        			Pancreas, Artificial*
		                        			
		                        		
		                        	
7.Current characteristics of dialysis therapy in Korea: 2015 registry data focusing on elderly patients.
Dong Chan JIN ; Sung Ro YUN ; Seoung Woo LEE ; Sang Woong HAN ; Won KIM ; Jongha PARK
Kidney Research and Clinical Practice 2016;35(4):204-211
		                        		
		                        			
		                        			Because of increases in the elderly population and diabetic patients, the proportion of elderly among dialysis patients has rapidly increased during the last decades. The mortality and morbidity of these elderly dialysis patients are obviously much higher than those of young patients, but large analytic studies about elderly dialysis patients' characteristics have rarely been published. The registry committee of the Korean Society of Nephrology has collected data about dialysis therapy in Korea through an Internet online registry program and analyzed the characteristics. A survey on elderly dialysis patients showed that more than 50% of elderly (65 years and older) patients had diabetic nephropathy as the cause of end-stage renal disease, and approximately 21% of elderly dialysis patients had hypertensive nephrosclerosis. The proportion of elderly hemodialysis (HD) patients with native vessel arteriovenous fistula as vascular access for HD was lower than that of young (under 65 years) HD patients (69% vs. 80%). Although the vascular access was poor and small surface area dialyzers were used for the elderly HD patients, the dialysis adequacy data of elderly patients were better than those of young patients. The laboratory data of elderly dialysis patients were not very different from those of young patients, but poor nutrition factors were observed in the elderly dialysis patients. Although small surface area dialyzers were used for elderly HD patients, the urea reduction ratio and Kt/V were higher in elderly HD patients than in young patients.
		                        		
		                        		
		                        		
		                        			Aged*
		                        			;
		                        		
		                        			Arteriovenous Fistula
		                        			;
		                        		
		                        			Diabetic Nephropathies
		                        			;
		                        		
		                        			Dialysis*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Internet
		                        			;
		                        		
		                        			Kidney Failure, Chronic
		                        			;
		                        		
		                        			Korea*
		                        			;
		                        		
		                        			Mortality
		                        			;
		                        		
		                        			Nephrology
		                        			;
		                        		
		                        			Nephrosclerosis
		                        			;
		                        		
		                        			Renal Dialysis
		                        			;
		                        		
		                        			Renal Replacement Therapy
		                        			;
		                        		
		                        			Urea
		                        			
		                        		
		                        	
8.Lessons from 30 years' data of Korean end-stage renal disease registry, 1985-2015.
Dong Chan JIN ; Sung Ro YUN ; Seoung Woo LEE ; Sang Woong HAN ; Won KIM ; Jongha PARK ; Yong Kyun KIM
Kidney Research and Clinical Practice 2015;34(3):132-139
		                        		
		                        			
		                        			The Korean Society of Nephrology (KSN) launched a nationwide official survey program about dialysis therapy in 1985. Nowadays, the accumulated data for 30 years by this "Insan Prof. Min Memorial end-stage renal disease (ESRD) Registry" program have been providing the essential information for dialysis clinical practice, academic nephrology research, and health management policy. We reviewed 30 years of data to identify important changes and implications for the future improvement of dialysis therapy in Korea. Hemodialysis patients, especially diabetics and elderly patients have increased in number very rapidly during recent years in Korea. The Korean prevalence rate of ESRD patients was about 70% of the United States and about 50% of Japan according to the international comparisons in the annual data report of United States Renal Data System. The blood pressure control, anemia control, and dialysis adequacy have continuously improved year by year. The importance of calcium and phosphorus control has also been increasing because of the increase in long-term dialysis patients. In addition, chronic dialysis complications should be closely monitored and dialysis modifications, such as hemodiafiltration therapy, might be considered. Because of the increase of private clinics and nursing hospitals in dialysis practice, the role of dialysis specialists and continuing education are thought to be essential. For strict cost-effective dialysis control of increasing elderly, diabetic, and long-term dialysis patients, the KSN ESRD patient registration should be run by the KSN and health ministry in cooperation, in which the dialysis fee reimbursement should be accompanied.
		                        		
		                        		
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Anemia
		                        			;
		                        		
		                        			Blood Pressure
		                        			;
		                        		
		                        			Calcium
		                        			;
		                        		
		                        			Dialysis
		                        			;
		                        		
		                        			Education, Continuing
		                        			;
		                        		
		                        			Fees and Charges
		                        			;
		                        		
		                        			Hemodiafiltration
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Information Systems
		                        			;
		                        		
		                        			Japan
		                        			;
		                        		
		                        			Kidney Failure, Chronic*
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Nephrology
		                        			;
		                        		
		                        			Nursing
		                        			;
		                        		
		                        			Peritoneal Dialysis
		                        			;
		                        		
		                        			Phosphorus
		                        			;
		                        		
		                        			Prevalence
		                        			;
		                        		
		                        			Renal Dialysis
		                        			;
		                        		
		                        			Specialization
		                        			;
		                        		
		                        			United States
		                        			
		                        		
		                        	
9.A Case of Egg-Shell Calcification of Renal Cell Carcinoma in Continuous Ambulatory Peritoneal Dialysis Patient with Sclerosing Encasulating Peritonitis.
Si Nae LEE ; Shin Il KIM ; Jee Young HAN ; Joon Ho SONG ; Seoung Woo LEE ; Moon Jae KIM
Soonchunhyang Medical Science 2014;20(2):140-144
		                        		
		                        			
		                        			Acquired cystic kidney disease (ACKD), a common complication in patients with end-stage renal disease, is characterized by more than three kidney cysts and normal or decreased sizes of both kidneys without any familial history of cystic kidney disease. In autosomal dominant polycystic kidney disease (ADPKD), however, both kidneys are usually enlarged. Extrarenal manifestations are common in ADPKD, including hepatic cysts, seminal vesicle cysts, mitral valve prolapse. A 40-year-old man presented to the emergency clinic at Inha University Hospital with severe abdominal pain, nausea, and vomiting for 3 days. He had been undergoing continuous ambulatory peritoneal dialysis (CAPD) for 15 years, but it was recently changed to hemodialysis owing to sclerosing encapsulating peritonitis (SEP). Radiologic imaging studies revealed bilateral enlarged kidneys with multiple eggshell calcified cysts and some hepatic cysts, which suggested ADPKD. He underwent left nephrectomy, and pathological tests revealed ACKD-associated renal cell carcinoma (RCC) confined to the resected kidney. He was treated with steroids for SEP, and the symptoms resolved. We herein report a case of ACKD-resembling ADPKD-that progressed to RCC in a patient with concurrent SEP who had been undergoing CAPD for 15 years.
		                        		
		                        		
		                        		
		                        			Abdominal Pain
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Carcinoma, Renal Cell*
		                        			;
		                        		
		                        			Emergencies
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Kidney
		                        			;
		                        		
		                        			Kidney Diseases, Cystic
		                        			;
		                        		
		                        			Kidney Failure, Chronic
		                        			;
		                        		
		                        			Mitral Valve Prolapse
		                        			;
		                        		
		                        			Nausea
		                        			;
		                        		
		                        			Nephrectomy
		                        			;
		                        		
		                        			Peritoneal Dialysis, Continuous Ambulatory*
		                        			;
		                        		
		                        			Peritonitis*
		                        			;
		                        		
		                        			Polycystic Kidney, Autosomal Dominant
		                        			;
		                        		
		                        			Renal Dialysis
		                        			;
		                        		
		                        			Renal Insufficiency, Chronic
		                        			;
		                        		
		                        			Seminal Vesicles
		                        			;
		                        		
		                        			Steroids
		                        			;
		                        		
		                        			Vomiting
		                        			
		                        		
		                        	
10.Application of an Insulin Analogue in Six Hypoglycemia-Prone Hemodialysis Patients with Type 2 Diabetes.
Gyung Eun KIM ; Seong Bin HONG ; Ju Young HAN ; Ji Hun JANG ; Dong Hyuk YANG ; Seoung Woo LEE ; Joon Ho SONG
Korean Journal of Medicine 2012;83(5):647-653
		                        		
		                        			
		                        			Day-to-day insulin requirements often change due to subtle variations in insulin metabolism in patients with type 2 diabetes undergoing hemodialysis. In such cases, intra-hemodialysis hypoglycemia frequently occurs and is a main factor interfering with the delivery of dialysis. As a result, it reduces the quality of life in patients undergoing hemodialysis. The long-acting insulin analogue glargine provides peakless, continuous release over 24 h that approximates a normal basal insulin pattern. Because it has no peak, its use in patients with diabetes undergoing hemodialysis would hypothetically be useful. Specifically, patients would be able to avoid intra-hemodialysis hypoglycemia without the necessity of skipping insulin administration on the day of hemodialysis and achieving adequate glucose control on other days. We recently experienced six cases that switched from treatment with intermediate-acting insulin to a long-acting insulin analogue, which provided better glycemic control by reducing hypoglycemia risk. Limited data are available in the literature concerning insulin analogue usage in patients with diabetes undergoing hemodialysis. Our experience suggests a large-scale prospective investigation is required on this issue.
		                        		
		                        		
		                        		
		                        			Dialysis
		                        			;
		                        		
		                        			Glucose
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypoglycemia
		                        			;
		                        		
		                        			Insulin
		                        			;
		                        		
		                        			Insulin, Long-Acting
		                        			;
		                        		
		                        			Kidney Failure, Chronic
		                        			;
		                        		
		                        			Quality of Life
		                        			;
		                        		
		                        			Renal Dialysis
		                        			;
		                        		
		                        			Insulin Glargine
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail